Drugs for Herpes Labialis (Oral Herpes) Market Report

Global and Region Drugs for Herpes Labialis (Oral Herpes) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：170
  • REPORT CODE：GMM978972
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Drugs for Herpes Labialis (Oral Herpes) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Drugs for Herpes Labialis (Oral Herpes)market, defines the market attractiveness level of Drugs for Herpes Labialis (Oral Herpes) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Drugs for Herpes Labialis (Oral Herpes) industry, describes the types of Drugs for Herpes Labialis (Oral Herpes) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Drugs for Herpes Labialis (Oral Herpes) market and the development prospects and opportunities of Drugs for Herpes Labialis (Oral Herpes) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Drugs for Herpes Labialis (Oral Herpes) market in Chapter 13.

    By Player:

    • Mylan

    • Hikma

    • Daewoong Pharmaceutical

    • Novartis

    • GSK

    • Med shine

    • Cadila

    • Livzon

    • Luoxin

    • Teva

    • Cipher

    • Apotex

    • Kelun Group

    • Haiwang

    • Blistex

    • Carmex

    • Bayer (Campho Phenique)

    By Type:

    • Aciclovir

    • Valacyclovir

    • Famciclovir

    • Docosanol

    • Other

    By End-User:

    • Other

    • Other

    • Other

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Drugs for Herpes Labialis (Oral Herpes) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Drugs for Herpes Labialis (Oral Herpes) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Drugs for Herpes Labialis (Oral Herpes) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Drugs for Herpes Labialis (Oral Herpes) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Drugs for Herpes Labialis (Oral Herpes) Market Analysis and Outlook to 2022

    • 7.1 Global Drugs for Herpes Labialis (Oral Herpes) Consumption (2017-2022)

    • 7.2 United States Drugs for Herpes Labialis (Oral Herpes) Consumption (2017-2022)

    • 7.3 Europe Drugs for Herpes Labialis (Oral Herpes) Consumption (2017-2022)

    • 7.4 China Drugs for Herpes Labialis (Oral Herpes) Consumption (2017-2022)

    • 7.5 Japan Drugs for Herpes Labialis (Oral Herpes) Consumption (2017-2022)

    • 7.6 India Drugs for Herpes Labialis (Oral Herpes) Consumption (2017-2022)

    • 7.7 South Korea Drugs for Herpes Labialis (Oral Herpes) Consumption (2017-2022)

    8 Region and Country-wise Drugs for Herpes Labialis (Oral Herpes) Market Analysis and Outlook to 2028

    • 8.1 Global Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast (2022-2028)

    • 8.2 United States Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast (2022-2028)

    • 8.3 Europe Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast (2022-2028)

    • 8.4 China Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast (2022-2028)

    • 8.5 Japan Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast (2022-2028)

    • 8.6 India Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast (2022-2028)

    • 8.7 South Korea Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast (2022-2028)

    9 Global Drugs for Herpes Labialis (Oral Herpes) Market Outlook by Types and Applications to 2022

    • 9.1 Global Drugs for Herpes Labialis (Oral Herpes) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Aciclovir Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Valacyclovir Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Famciclovir Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Docosanol Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Drugs for Herpes Labialis (Oral Herpes) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Other Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Other Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Drugs for Herpes Labialis (Oral Herpes) Market Outlook by Types and Applications to 2028

    • 10.1 Global Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Aciclovir Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Valacyclovir Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Famciclovir Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Docosanol Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Other Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Other Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Drugs for Herpes Labialis (Oral Herpes) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Drugs for Herpes Labialis (Oral Herpes) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Drugs for Herpes Labialis (Oral Herpes) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Drugs for Herpes Labialis (Oral Herpes) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Drugs for Herpes Labialis (Oral Herpes) Market Competitive Analysis

    • 14.1 Mylan

      • 14.1.1 Mylan Company Details

      • 14.1.2 Mylan Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.2 Hikma

      • 14.2.1 Hikma Company Details

      • 14.2.2 Hikma Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.3 Daewoong Pharmaceutical

      • 14.3.1 Daewoong Pharmaceutical Company Details

      • 14.3.2 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.4 Novartis

      • 14.4.1 Novartis Company Details

      • 14.4.2 Novartis Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.5 GSK

      • 14.5.1 GSK Company Details

      • 14.5.2 GSK Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GSK Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.6 Med shine

      • 14.6.1 Med shine Company Details

      • 14.6.2 Med shine Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.7 Cadila

      • 14.7.1 Cadila Company Details

      • 14.7.2 Cadila Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.8 Livzon

      • 14.8.1 Livzon Company Details

      • 14.8.2 Livzon Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.9 Luoxin

      • 14.9.1 Luoxin Company Details

      • 14.9.2 Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.10 Teva

      • 14.10.1 Teva Company Details

      • 14.10.2 Teva Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Teva Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.11 Cipher

      • 14.11.1 Cipher Company Details

      • 14.11.2 Cipher Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.12 Apotex

      • 14.12.1 Apotex Company Details

      • 14.12.2 Apotex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.13 Kelun Group

      • 14.13.1 Kelun Group Company Details

      • 14.13.2 Kelun Group Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Kelun Group Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.14 Haiwang

      • 14.14.1 Haiwang Company Details

      • 14.14.2 Haiwang Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.15 Blistex

      • 14.15.1 Blistex Company Details

      • 14.15.2 Blistex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.16 Carmex

      • 14.16.1 Carmex Company Details

      • 14.16.2 Carmex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • 14.17 Bayer (Campho Phenique)

      • 14.17.1 Bayer (Campho Phenique) Company Details

      • 14.17.2 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Drugs for Herpes Labialis (Oral Herpes)

    • Figure Drugs for Herpes Labialis (Oral Herpes) Picture

    • Table Global Drugs for Herpes Labialis (Oral Herpes) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Drugs for Herpes Labialis (Oral Herpes) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Drugs for Herpes Labialis (Oral Herpes) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Drugs for Herpes Labialis (Oral Herpes) Consumption by Country (2017-2022)

    • Figure United States Drugs for Herpes Labialis (Oral Herpes) Consumption and Growth Rate (2017-2022)

    • Table Europe Drugs for Herpes Labialis (Oral Herpes) Consumption and Growth Rate (2017-2022)

    • Figure China Drugs for Herpes Labialis (Oral Herpes) Consumption and Growth Rate (2017-2022)

    • Figure Japan Drugs for Herpes Labialis (Oral Herpes) Consumption and Growth Rate (2017-2022)

    • Figure India Drugs for Herpes Labialis (Oral Herpes) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Drugs for Herpes Labialis (Oral Herpes) Consumption and Growth Rate (2017-2022)

    • Figure Global Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast by Country (2022-2028)

    • Figure United States Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Drugs for Herpes Labialis (Oral Herpes) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Aciclovir Consumption and Growth Rate (2017-2022)

    • Figure Global Valacyclovir Consumption and Growth Rate (2017-2022)

    • Figure Global Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Global Docosanol Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Aciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Valacyclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Docosanol Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Drugs for Herpes Labialis (Oral Herpes) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Drugs for Herpes Labialis (Oral Herpes) Export by Region (Top 5 Countries) (2017-2028)

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Hikma (Foundation Year, Company Profile and etc.)

    • Table Hikma Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hikma Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Daewoong Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Med shine (Foundation Year, Company Profile and etc.)

    • Table Med shine Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Med shine Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Cadila (Foundation Year, Company Profile and etc.)

    • Table Cadila Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cadila Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Livzon (Foundation Year, Company Profile and etc.)

    • Table Livzon Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Livzon Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Luoxin (Foundation Year, Company Profile and etc.)

    • Table Luoxin Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Luoxin Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Cipher (Foundation Year, Company Profile and etc.)

    • Table Cipher Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cipher Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Apotex (Foundation Year, Company Profile and etc.)

    • Table Apotex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apotex Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Kelun Group (Foundation Year, Company Profile and etc.)

    • Table Kelun Group Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kelun Group Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Haiwang (Foundation Year, Company Profile and etc.)

    • Table Haiwang Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Haiwang Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Blistex (Foundation Year, Company Profile and etc.)

    • Table Blistex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Blistex Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Carmex (Foundation Year, Company Profile and etc.)

    • Table Carmex Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Carmex Drugs for Herpes Labialis (Oral Herpes) Product and Service

    • Table Bayer (Campho Phenique) (Foundation Year, Company Profile and etc.)

    • Table Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US